摘要
N末端脑钠肽前体(NT-proBNP)可以反映心肌细胞受到容量负荷和压力负荷的大小。近年对于维持性血液透析(MHD)患者NT-proBNP的相关研究逐渐增多。本文综述NT-proBNP的特性及其对于MHD患者病情的监测价值,主要包括容量状态、心血管事件、死亡风险等。
N-terminal brain natriuretic peptide （NT-proBNP） is synthesized and secreted from cardiac myocytes in case of pressure or volume overload. In recent years, more and more studies about NT-proBNP have been carried out among maintenance hemodialysis （MHD） people. This review describes the monitoring value of serum NT-proBNP on MHD patients including volume status, cardiovascular event and death risk.
出处
《世界临床药物》
CAS
2014年第8期506-510,共5页
World Clinical Drug
基金
北京市海淀区科技基本项目(K20110068)
